Selected article for: "abnormal inflammatory and lung inflammation"
Author: Barbosa, Lucas Cunha; Gonçalves, Thaynan Lopes; de Araujo, Luanna Prudencio; Rosario, Luciane Vieira de Oliveira; Ferrer, Valéria Pereira
Title: Endothelial cells and SARS-CoV-2: An intimate relationship
  • Cord-id: hxuyx9rb
  • Document date: 2021_1_8
    • ID: hxuyx9rb
    Snippet: Angiotensin-converting enzyme 2 (ACE2) is an important player of the renin-angiotensin-aldosterone system (RAAS) in regulating the conversion of angiotensin II into angiotensin (1-7). While expressed on the surface of human cells, such as lung, heart, kidney, neurons, and endothelial cells (EC), ACE2 is the entry receptor for SARS-CoV-2. Here, we would like to highlight that ACE2 is predominant on the EC membrane. Many of coronavirus disease 2019 (COVID-19) symptoms have been associated with the
    Document: Angiotensin-converting enzyme 2 (ACE2) is an important player of the renin-angiotensin-aldosterone system (RAAS) in regulating the conversion of angiotensin II into angiotensin (1-7). While expressed on the surface of human cells, such as lung, heart, kidney, neurons, and endothelial cells (EC), ACE2 is the entry receptor for SARS-CoV-2. Here, we would like to highlight that ACE2 is predominant on the EC membrane. Many of coronavirus disease 2019 (COVID-19) symptoms have been associated with the large recruitment of immune cells, directly affecting EC. Additionally, cytokines, hypoxia, and complement activation can trigger the activation of EC leading to the coagulation cascade. The EC dysfunction plus the inflammation due to SARS-CoV-2 infection may lead to abnormal coagulation, actively participating in thrombo-inflammatory processes resulting in vasculopathy and indicating poor prognosis in patients with COVID-19. Considering the intrinsic relationship between EC and the pathophysiology of SARS-CoV-2, EC-associated therapies such as anticoagulants, fibrinolytic drugs, immunomodulators, and molecular therapies have been proposed. In this review, we will discuss the role of EC in the lung inflammation and edema, in the disseminate coagulation process, ACE2 positive cancer patients, and current and future EC-associated therapies to treat COVID-19.

    Search related documents:
    Co phrase search for related documents
    • aberrant inflammatory response and acute sars respiratory distress syndrome: 1, 2
    • aberrant inflammatory response and adaptive immune response: 1
    • aberrant inflammatory response and adaptive response: 1
    • abnormal coagulation and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • abnormal coagulation and acute inflammation: 1, 2
    • abnormal coagulation and adaptive response: 1
    • activation recruitment and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • activation recruitment and acute inflammation: 1, 2, 3
    • activation recruitment and adaptive immune response: 1, 2, 3, 4
    • activation recruitment and adaptive response: 1, 2, 3, 4, 5
    • activity inhibit and acute ards respiratory distress syndrome: 1, 2
    • activity inhibit and adaptive response: 1
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and adaptive response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute hyperinflammation and adaptive immune response: 1
    • acute hyperinflammation and adaptive response: 1
    • acute inflammation and adaptive immune response: 1, 2, 3, 4
    • acute inflammation and adaptive response: 1, 2, 3, 4, 5, 6, 7
    • acute inflammation and adhesion interaction: 1